Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics

Report Highlights

The global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.

Report Includes

• 53 data tables and 29 additional tables
• An overview of the global market for polymerase chain reaction (PCR) for point-of-care (POC) diagnostics, along with an evaluation of each market segment’s future commercial potential
• Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, and projected CAGRs through 2029
• Evaluation of the current market size and revenue growth prospects, along with a market share analysis by product, analyte, application and region
• Identification of emerging market opportunities, technology trends and issues, and regulatory frameworks pertaining to PCR technology
• A look at the competitive landscape, including an analysis of the impact of COVID-19 as well as the FDA’s contribution to COVID-19 diagnostic testing
• A review of patents and new developments in PCR POC technologies
• Profiles of leading market participants, including Abbott, Danaher (Cepheid), Roche, Thermo-Fisher Scientific and QIAGEN

Report Scope

This report provides a comprehensive summary of the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics, along with a detailed competitive landscape and profiles of key market players that include revenue, product portfolios and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges, and opportunities. This research study discusses historical, current and potential market size. It will enable market players and new entrants to make informed decisions regarding the production and licensing of goods and services. Organizations, distributors and exporters should find useful information regarding market development and trends. The study segments the market on the basis of product type, such as POC PCR analyzers, consumables, single analyte, multi-analyte and applications. Geographical market analysis is provided for all the major segments. The report offers country-level analysis of markets to provide a better understanding of the major segments.

The market is divided into segments and by application/industry:

By Product type:

• POC PCR analyzers.
• Consumables.

By analyte:

• POC PCR analyzers.
  • Single analyte.
  • Multi-analyte.
• Consumables.
  • Single analyte.
  • Multi-analyte.

By Application:

• Infectious diseases.
• Sexually transmitted diseases (STIs).
• Other diseases.

Each area is covered in detail, identifying current products in the market in the base year (2023), measuring the current market size and identifying current and potential market drivers, forecasting for 2029, assessing current and potential competitors, and identifying current competitor market shares for 2023.

Analyst Credentials

Gundreddy Gopinadh– Associate Consultant-Life Sciences Research
Gopinadh is an experienced professional with nearly nine years in the market research industry and experience in research and analysis, specializing in medical devices, pharmaceuticals, biotechnology, and in-vitro diagnostics verticals. He is an expert in handling custom projects by gathering data points, analyzing market trends, and ultimately providing clients with accurate market size numbers, actionable insights, and recommendations based on their unique business needs. Academically, Gopinadh holds a master’s degree in biotechnology from VIT University.

Consulting Editor’s Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.